20 May 2013
Keywords: open-label, study, cop-1, ms, results, teva, pharmaceutical
Article | 08 November 1993
The results of an open-label study of Teva Pharmaceutical Industries'
copolymer-1 have been presented at the European Conference on Treatment
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 November 1993
15 November 1993
1 November 1993
© 2013 thepharmaletter.com